1-3 of 3
Arooj Khan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma

Donna E. Reece, MD, Esther Masih-Khan, PhD, Arooj Khan, Saima Dean, Sharon Fung, Peter Anglin, MD, Christine Chen, MD, Vishal Kukreti, MD, FRCPC, Joseph R. Mikhael, MD, Suzanne Trudel, MD, MSC, FRCPC
Journal: Blood
Blood (2010) 116 (21): 3055.
https://doi.org/10.1182/blood.V116.21.3055.3055
Published: 2010
Journal Articles

Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma.

Donna E. Reece, MD, FRCPC, Esther Masih-Khan, PhD, Arooj Khan, Saima Dean, Peter Anglin, MD, Christine Chen, MD, Vishal Kukreti, MD, FRCPC, Joseph R. Mikhael, MD, Suzanne Trudel
Journal: Blood
Blood (2009) 114 (22): 1874.
https://doi.org/10.1182/blood.V114.22.1874.1874
Published: 2009
Journal Articles

Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid ® ) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma.

Donna E. Reece, MD, Esther Masih-Khan, Arooj Khan, Peter Anglin, MD, Christine Chen, MD, Vishal Kukreti, MD, Joseph R. Mikhael, MD, Suzanne Trudel, MD
Journal: Blood
Blood (2008) 112 (11): 1723.
https://doi.org/10.1182/blood.V112.11.1723.1723
Published: 2008